Mrudula Dhavala M.s

Associate Director, DSPV Compliance & Operations at Blueprint Medicines

Mrudula Dhavala M.S, RAC(US) has a diverse work experience in the pharmaceutical industry, with a focus on drug safety, pharmacovigilance, and regulatory affairs. Mrudula is currently working at Blueprint Medicines as an Associate Director, overseeing compliance and operations in drug safety and pharmacovigilance. Prior to that, they held positions at Vertex Pharmaceuticals, where they served as a Senior Manager in drug safety and pharmacovigilance, as well as a Pharmacovigilance Associate III and a Regulatory Information and Publishing Specialist.

In addition to their industry experience, they have also worked in academia at MCPHS University, where they served as a Laboratory Basic Chemistry Instructor and a Teaching Assistant. Furthermore, they held roles at ISPE as the Boston MCPHS Chapter Secretary and at Syner-G Pharma CMC Consulting, LLC as a Regulatory CMC Intern. Mrudula also interned at Vertex Pharmaceuticals as a Quality Assurance Intern.

Overall, Mrudula Dhavala brings a wealth of experience in drug safety, pharmacovigilance, regulatory affairs, teaching, and industry organizations to their current role at Blueprint Medicines.

Mrudula Dhavala M.S, RAC(US) completed their education in Pharmacy with a focus on Regulatory Affairs and Health Policy. Mrudula obtained a Master's degree from Massachusetts College of Pharmacy and Health Sciences from 2013 to 2015. Prior to that, they earned a Bachelor's degree in Pharmacy Administration and Pharmacy Policy and Regulatory Affairs from Andhra University, where they studied from 2008 to 2012. Additionally, they hold a Regulatory Affairs Certification from the Regulatory Affairs Professionals Society (RAPS), although the exact date of certification is unknown.

Links

Previous companies

Syner-G BioPharma Group logo
Vertex Pharmaceuticals logo
ISPE logo

Timeline

  • Associate Director, DSPV Compliance & Operations

    January, 2023 - present

  • Senior Manager - Drug Safety And Pharmacovigilance

    July, 2020

  • Manager - Drug Safety & Pharmacovigilance

    October, 2018